Net income (loss) per
share:
Basic $0.94 $- $(0.036) $(0.367)
Diluted (1) $0.91 $(0.024) $(0.033) $(0.344)
Weighted average shares
outstanding:
Basic 265,418
Diluted (1) 273,688 9,686
FAS 123R GAAP
Amortization Expense As Reported
Income Statement Classification:
Total revenues $1,036,758
Cost of products and services sold $(7,137) $(262,657)
Selling, general and administrative $(23,334) $(307,631)
Research and development $(13,128) $(191,588)
Amortization of intangibles $(51,804) $(51,804)
Purchase of in-process
research and development $(106,350)
Equity in income (loss) of
equity method investments $(830) $8,489
Minority interest $-
Gains (losses) on investments
in equity securities $(969)
Other $(7,228)
Investment income $18,509
Interest expense $(2,864)
Summary:
Income (loss) before income taxes $(52,634) $(43,599) $132,665
(Provision for) benefit from
income taxes $19,985 $12,920 $(53,766)
Net income (loss) $(32,649) $(30,679) $78,899
Net income (loss) per
share:
Basic
'/>"/>
| SOURCE Genzyme Corporation Copyright©2008 PR Newswire. All rights reserved |